AzTrials
AzTrials

StrokeNCT03171012

Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke

A study testing Lower limbs CRT, Upper limbs CRT and Proprioceptive Neuromuscular Facilitation in people with Stroke and Chest Wall Disorder, run by Universidade Federal do Rio Grande do Norte at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Post-stroke hemiparesis causes sequelae in the limbs and also in the trunk and abdomen structures. The level of physical activity decreases and cardiorespiratory training(CRT) is indicated to this population to improve the functions of several systems (respiratory, cardiovascular, muscular). Read more about this study

Who is it for?
Ages 21 to 65 years
Conditions the study is for
Stroke, Chest Wall Disorder, Quality of Life
What is being tested?
Lower limbs CRT, Upper limbs CRT and Proprioceptive Neuromuscular Facilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteBrazil
Study dates
19 Jun 2017to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have clinical diagnosis of ischemic or hemorrhagic stroke,
  • primary for more than six months resulting in hemiparesis;
  • Have mental competence assessed through the Mini-Exam of the Mental State-MMSE;
  • Be able to walk 10 meters independently, with or without assistive device;
  • Absence of other neurological or orthopedic deficiencies unrelated to stroke;
  • Without report of associated pulmonary pathology and not be smoker or ex-smoker.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

RENATA SOUZA, MASTER contact

55 81 999069957

FTRJPS@GMAIL.COM

Brazil1 site, 1 recruiting
  • Universidade Federal de Pernambuco

    Recife, Pernambuco, 50740 - 560

    Renata Souza, +55 81 999069957, ftrjps@gmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: Proprioceptive Neuromuscular Facilitation Repercussions Associated With Cardiorespiratory Training in Postal Individuals Stroke to the Functions Motor, Respiratory and Quality of Life: Randomized Controlled Trial

Post-stroke hemiparesis causes sequelae in the limbs and also in the trunk and abdomen structures. The level of physical activity decreases and cardiorespiratory training(CRT) is indicated to this population to improve the functions of several systems (respiratory, cardiovascular, muscular). The application of Proprioceptive Neuromuscular Facility(PNF) would imply in the awareness and greater harmony of the functions performed by the trunk of this individual. The objective of this study is to evaluate the effects of respiratory and trunk characteristics of the PNF associated with Cardiorespiratory training in quality of life, gait, distance traveled, peak oxygen consumption, respiratory muscle strength, thoracic cavity volumes, mobility and diaphragmatic thickness of individuals with post stroke.

Read the detailed description

Clinical, randomized, blind and allocation. Forty individuals post-stroke will be randomized into four groups: Experimental Lower Limbs(submitted to LL's CRT associated with PNF); Group control Lower Limbs (submitted LL's CRT associated with respiration). Experimental Upper Limbs (submitted to UP's CRT associated with PNF) and Group control Upper Limbs (submitted to UP's CRT associated with respiration). Individuals will be assessed before and immediately after 20 program sessions and one month after the end of treatment. Outcome measures shall be measured by: Stroke Specific Quality of Life Scale; Inertial gear sensor; Maximum volume of oxygen; Spirometry and manovacuometry; Ultrasound of mobility and thickness diaphragmatic; compartmental volumes of the rib cage with opto plethysmography electronics.

For the four groups, the treatment program will have the total duration of one hour including: ten minutes of stretching (five minutes before and five minutes after the therapeutic intervention), ten minutes of rest and 40 minutes of aerobic treatment associated to PNF or to respiration, being performed in 20 Sessions three times a week. The order of application of the techniques will be random, being held until the end of the intervention period. For therapy with the CRT used the cycle ergometer for lower or upper limbs, Based on the criteria of the American College of Sports Medicine and monitoring constant blood pressure, oxygen saturation and perceived exertion. The PNF patterns will be performed in seated, dorsal, ventral and side. The breathing exercises will be performed at the same time and in the positions of the PNF. To analyze the data and to achieve the objectives appropriate statistical tests shall be used, according to the normality of and characteristics of the variables.

Being tested
Lower limbs CRT, Upper limbs CRT, Proprioceptive Neuromuscular Facilitation, respiration
Keywords
Muscle Stretching Exercises
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lower limbs CRTOther

    cycle ergometer for lower limbs

  • Upper limbs CRTOther

    cycle ergometer for upper limbs

  • Proprioceptive Neuromuscular FacilitationOther

    Proprioceptive Neuromuscular Facilitation patterns will be performed in seated, dorsal, ventral and side.

  • respirationOther

    respiration

Study groups in NCT03171012
Study groupRoleWhat they receive
Lower limbs CRT+ PNFExperimentalLower Limbs Cardiorespiratory training associated with Proprioceptive Neuromuscular Facilitation
Receives: Other: Lower limbs CRT; Other: Proprioceptive Neuromuscular Facilitation
Lower limbs CRT + respirationActive comparatorLower limbs Cardiorespiratory training associated with respiration
Receives: Other: Lower limbs CRT; Other: respiration
Upper limbs CRT + PNFExperimentalUpper limbs Cardiorespiratory training associated with Proprioceptive Neuromuscular Facilitation
Receives: Other: Upper limbs CRT; Other: Proprioceptive Neuromuscular Facilitation
Upper limbs CRT + respirationActive comparatorUpper limbs Cardiorespiratory training associated with respiration
Receives: Other: Upper limbs CRT; Other: respiration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygen uptake

    maximum oxygen volume consumed during the 6-minute walk test

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  2. Balance

    The scale assesses the balance based on 14 common items of day-to-day.

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  3. Quality of life

    12 domains: Energy (3 items); Family Relationships (3 items); Language (5 items); Mobility (6 items); Mood (5 items); Personality (3 items); Self-Care (5 items), Superior Member Function (5 items), Social Relations (5 items), Memory / Concentration (3 items), Vision (3 items) and Work / Productivity (3 items).

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  4. Gait

    Wireless system consisting of an inertial sensor, consisting of a 3-axis accelerometer, a magnetic sensor and a 3-axis gyroscope, which positioned in L5 allows a functional gait analysis. The system calculates from the data obtained all the temporal and spatial gait parameters required to perform a diagnosis or to define a training strategy. The distance traveled, time of support and balance, step size.

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  5. Compartmental volumes of the rib cage

    Analysis of the kinematics of the thoracic wall through the optical-electronic plethysmograph

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

Secondary outcomes (6)
  1. Respiratory function

    Spirometry: Will be measured slow vital capacity (Measured in liters), Inspiratory capacity (Measured in liters), forced expiratory volume in the first second (Measured in liters), Forced vital capacity (Measured in liters), forced expiratory volume ratio in the first second by forced vital capacity, peak expiratory flow (Measured in liters per minute).

    Measured: Three months total:After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  2. Inspiratory muscle strength

    Manovacuometry: Maximal Inspiratory pressure (MIP), Measured in centimeters of water

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  3. Expiratory muscle strength

    Manovacuometry: maximal expiratory pressure (MEP), Measured in centimeters of water

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  4. Diaphragmatic thickness

    Measurement of the diaphragmatic thickness from the middle of the pleural line to the middle of the peritoneal line.

    Measured: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  5. Mobility diaphragmatic

    Using convex transducer (3.5MHz) positioned in the right axillary line below the costal margin, the examiner will maintain a firm hand towards the cranial direction. The cranio-caudal excursions of the diaphragm during quiet and forced breathing will record sinusoidal curves, which will represent the diaphragmatic mobility when the trajectory between the baseline at the beginning of the inspiration and the line obtained at the peak of the inspiration is verified.

    Measured: Three months total:After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

  6. Oxygen Uptake Efficiency Slope

    The OUES reflects the relationship between oxygen uptake(˙VO 2 in ml/min) and total ventilation (VE in L/min) and is best described by a single exponential function in almost all subjects.

    This index was determined by the following equation: VO2 = a log10VE + b When VO 2 in ml/min is plotted on the y axis and VE in L/min is plotted on the semilog transformed x axis, the slope of this linear relationship, "a", represents the OUES.

    Measured: Three months total:After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2017
  2. Study start19 Jun 2017
  3. Primary completionDec 2024 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Forty individuals into four groups: Experimental Lower Limbs (LL's CRT with PNF); Group control Lower Limbs (LL's CRT with respiration). Experimental Upper Limbs (UP's CRT with PNF) and Group control Upper Limbs (UP's CRT with respiration). Individuals will be assessed before and immediately after 20 program sessions and one month after the end of treatment. The treatment program will have the full duration of One hour including: ten minutes of stretching (five minutes before and five Minutes after the therapeutic intervention), ten minutes of rest and 40 minutes of Aerobic treatment associated with PNF or to respiration, being performed in 20 Sessions three times a week. For therapy with the CRT used the cycle ergometer for lower or upper limbs, Based on the criteria of the ACSM and monitoring Constant blood pressure, oxygen saturation and perceived exertion. The PNF patterns will be performed in seated, dorsal, ventral and Side.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03171012
Sponsor's protocol ID
LACAP UFPE/UFRN
Status last verified
May 2023
First submitted
23 May 2017
Last updated
11 May 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • de Souza RJP, Brandao DC, Martins JV, Fernandes J, Dornelas de Andrade A. Addition of proprioceptive neuromuscular facilitation to cardiorespiratory training in patients poststroke: study protocol for a randomized controlled trial. Trials. 2020 Feb 14;21(1):184. doi: 10.1186/s13063-019-3923-1.

    PubMed 32059691

Questions about this trial

What is this clinical trial studying?

A study testing Lower limbs CRT, Upper limbs CRT and Proprioceptive Neuromuscular Facilitation in people with Stroke and Chest Wall Disorder, run by Universidade Federal do Rio Grande do Norte at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact RENATA SOUZA, MASTER (55 81 999069957, FTRJPS@GMAIL.COM), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygen uptake (time frame: Three months total: After 20 sessions of intervention(2 months) and after 1 months without treatment (follow-up)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03171012, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in